pubmed:abstractText |
This subanalysis of CURRENT, an open-label, 6-month, multicenter study, assesses changes in gastrointestinal (GI) tolerability with once-monthly oral ibandronate in women who switched from once-weekly bisphosphonates and had reported GI symptoms with their previous weekly bisphosphonate regimen.
|
pubmed:affiliation |
Department of Medicine, Institute on Aging, Universityof Wisconsin-Madison, 2870 University Avenue, Madison, WI 53705, USA. nbinkley@wisc.edu
|